-
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Tuesday, May 14, 2024 - 9:27am | 573Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced its financial results on Tuesday for the first quarter of fiscal 2024. CEO Aras Azadian called it its "best quarter.” In addition to being its first EBITDA-positive quarter, it also saw...